These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 31207758)

  • 1. Long-Term Consequences of Foodborne Toxoplasmosis: Effects on the Unborn, the Immunocompromised, the Elderly, and the Immunocompetent
    Smith JL
    J Food Prot; 1997 Dec; 60(12):1595-1611. PubMed ID: 31207758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recognition of tissue cyst-specific antigens in reactivating toxoplasmosis.
    McHugh TD; Bathgate T; Mangan J; Johnson JD; Holliman RE; Butcher PD
    J Med Microbiol; 1997 Jul; 46(7):587-95. PubMed ID: 9236743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxoplasmosis in pregnancy: prevention, screening, and treatment.
    Paquet C; Yudin MH;
    J Obstet Gynaecol Can; 2013 Jan; 35(1):78-81. PubMed ID: 23343802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Engineered Expression of Mitochondrial Association Factor 1b on
    English ED; Boyle JP
    mSphere; 2018 Oct; 3(5):. PubMed ID: 30333181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pathway to cure chronic infection with Toxoplasma gondii through immunological intervention.
    Suzuki Y
    Parasitol Int; 2021 Apr; 81():102259. PubMed ID: 33271362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Foodborne transmission of Toxoplasma gondii infection in the last decade. An overview.
    Almeria S; Dubey JP
    Res Vet Sci; 2021 Mar; 135():371-385. PubMed ID: 33148402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Toxoplasmosis and immunosuppression].
    Djurković-Djaković O
    Srp Arh Celok Lek; 1998; 126(5-6):197-203. PubMed ID: 9863381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toxoplasma gondii antibody profile in HIV-1-infected and uninfected pregnant women and the impact on congenital toxoplasmosis diagnosis in Rio de Janeiro, Brazil.
    Fernandes MA; Batista GI; Carlos Jda C; Gomes IM; Azevedo KM; Setúbal S; Oliveira SA; Velarde LG; Cardoso CA
    Braz J Infect Dis; 2012; 16(2):170-1174. PubMed ID: 22552460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Animals are key to human toxoplasmosis.
    Schlüter D; Däubener W; Schares G; Groß U; Pleyer U; Lüder C
    Int J Med Microbiol; 2014 Oct; 304(7):917-29. PubMed ID: 25240467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenosine metabolism in Toxoplasma gondii: potential targets for chemotherapy.
    el Kouni MH
    Curr Pharm Des; 2007; 13(6):581-97. PubMed ID: 17346176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Rudolf-Virchow Prize 1998. Award lecture. Toxoplasmosis: a model infection for studying systemic and intracerebral immune reactions].
    Deckert-Schlüter M
    Verh Dtsch Ges Pathol; 1998; 82():9-22. PubMed ID: 10095413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biotechnological Based Recombinant Protein Vaccines Developed Against Toxoplasmosis.
    Karakavuk T; Gül C; Karakavuk M; Gül A; Erkunt Alak S; Can H; Ün C; Döşkaya M; Gürüz AY; Değirmenci Döşkaya A
    Turkiye Parazitol Derg; 2022 Nov; 46(4):342-357. PubMed ID: 36444412
    [No Abstract]   [Full Text] [Related]  

  • 13. [Immunity in Toxoplasma gondii infections].
    Długońska H
    Postepy Hig Med Dosw; 2000; 54(1):53-65. PubMed ID: 10803024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the mood-stabilizing agent valproic acid as a preventative for toxoplasmosis in mice and activity against tissue cysts in mice.
    Goodwin DG; Strobl J; Mitchell SM; Zajac AM; Lindsay DS
    J Parasitol; 2008 Apr; 94(2):555-7. PubMed ID: 18564764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of Toxoplasma gondii vaccine: A global challenge.
    Verma R; Khanna P
    Hum Vaccin Immunother; 2013 Feb; 9(2):291-3. PubMed ID: 23111123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phytoecdysteroids as modulators of the Toxoplasma gondii growth rate in human and mouse cells.
    Dzitko K; Grzybowski MM; Pawełczyk J; Dziadek B; Gatkowska J; Stączek P; Długońska H
    Parasit Vectors; 2015 Aug; 8():422. PubMed ID: 26272689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strain- and Dose-Dependent Reduction of
    Jennes M; De Craeye S; Devriendt B; Dierick K; Dorny P; Cox E
    Front Cell Infect Microbiol; 2017; 7():232. PubMed ID: 28642841
    [No Abstract]   [Full Text] [Related]  

  • 18. Recombinant
    Czarnewski P; Araújo ECB; Oliveira MC; Mineo TWP; Silva NM
    Front Cell Infect Microbiol; 2017; 7():142. PubMed ID: 28487847
    [No Abstract]   [Full Text] [Related]  

  • 19. Recurrent headache as the main symptom of acquired cerebral toxoplasmosis in nonhuman immunodeficiency virus-infected subjects with no lymphadenopathy: the parasite may be responsible for the neurogenic inflammation postulated as a cause of different types of headaches.
    Prandota J
    Am J Ther; 2007; 14(1):63-105. PubMed ID: 17303977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pathogenicity and virulence of
    Sanchez SG; Besteiro S
    Virulence; 2021 Dec; 12(1):3095-3114. PubMed ID: 34895084
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.